Sanofi Returning Zantac OTC Heartburn Remedy Brand To US Market Formulated With Famotidine

Consumer Health Gets Little Mention In Q1 Results After Sales Dip 7%

Along with its Q1 results including a 7.3% drop in consumer health sales to €1.11bn ($1.35bn), Sanofi announces 10-mg famotidine tablets branded Zantac 360° will be available in the US in June.

Sanofi's consumer health care results factored so little in its latest quarter that it wouldn’t have mentioned a brand in the category if not for its pending relaunch of OTC heartburn remedy Zantac with famotidine as the active ingredient.

The French pharma on 28 April, along with its first-quarter results including a 7.3% drop in consumer health sales to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Ingredients & Safety

GSCF: ‘No One Size Fits All’ Solution To Tricky Sustainable Blister Pack Challenge

 
• By 

A series of research papers recently published by the Global Self-Care Federation indicate that industry will need to be pragmatic about alternatives to PVC in medicine blister packs.

EFSA: ‘A Dose Of Estragole Without A Harmful Effect Cannot Be Established’

 
• By 

Dietary supplements containing estragole may have to be removed from the European Union market due to carcinogenic risk, according to a draft scientific opinion from EFSA that is currently out for consultation.

Urban Wastewater Directive: AESGP Requests Intervention In EFPIA’s Legal Action

 
• By 

AESGP has formally submitted a request to the General Court of the European Union to intervene in the European Federation of Pharmaceutical Industries and Association’s legal action against the revised EU Urban Wastewater Directive.

Gardenia Blue, OrangeOvation, StellarYellow Latest Natural Pivots In US Food Color Market

 

FDA’s fourth approval in past two months for color derived from natural sources to use in foods is Gardenia Blue Interest Group’s color additive petition for gardenia blue. Lycored launches StellarYellow and C Clear as alternatives for synthetic dyes yellow Nos. 5 and 6 and OrangeOvation C Clear for

More from HBW Insight

PLT Health Wants Sports Nutrition Marketers To Know Consumers Like ‘Feeling Good’

 

Nutritional ingredient developer publishes results survey, with responses from 546 men and women in five countries, in a report looking at trends in cognitive and mood and with findings on consumers’ active nutrition goals, with a focus on the “concept of feeling good.”

New US FDA Chief Counsel More Familiar With Trump World Than Food and Drug Law

 

Sean Keveney is largely unknown in the FDA law space, but likely is familiar and connected to the White House given his work on Trump’s antisemitism taskforce.

People On The Move: Appointments At Enzymatica, Haleon, Futura

 
• By 

A round up of the latest moves in Europe's consumer health market: Enzymatica appoints CEO; Haleon hires DACH marketing chief; Futura confirms interim CEO.